Crippa, S.; Santi, L.; Bosotti, R.; Porro, G.; Bernardo, M.E.
Bone Marrow-Derived Mesenchymal Stromal Cells: A Novel Target to Optimize Hematopoietic Stem Cell Transplantation Protocols in Hematological Malignancies and Rare Genetic Disorders. J. Clin. Med. 2020, 9, 2.
https://doi.org/10.3390/jcm9010002
AMA Style
Crippa S, Santi L, Bosotti R, Porro G, Bernardo ME.
Bone Marrow-Derived Mesenchymal Stromal Cells: A Novel Target to Optimize Hematopoietic Stem Cell Transplantation Protocols in Hematological Malignancies and Rare Genetic Disorders. Journal of Clinical Medicine. 2020; 9(1):2.
https://doi.org/10.3390/jcm9010002
Chicago/Turabian Style
Crippa, Stefania, Ludovica Santi, Roberto Bosotti, Giulia Porro, and Maria Ester Bernardo.
2020. "Bone Marrow-Derived Mesenchymal Stromal Cells: A Novel Target to Optimize Hematopoietic Stem Cell Transplantation Protocols in Hematological Malignancies and Rare Genetic Disorders" Journal of Clinical Medicine 9, no. 1: 2.
https://doi.org/10.3390/jcm9010002
APA Style
Crippa, S., Santi, L., Bosotti, R., Porro, G., & Bernardo, M. E.
(2020). Bone Marrow-Derived Mesenchymal Stromal Cells: A Novel Target to Optimize Hematopoietic Stem Cell Transplantation Protocols in Hematological Malignancies and Rare Genetic Disorders. Journal of Clinical Medicine, 9(1), 2.
https://doi.org/10.3390/jcm9010002